Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.

Eur Respir J · 2019 · PMC6422836 · PMID 30578394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Mean/median weight was higher in the PBI-4050+pirfenidone group than in the other two treatment groups, but these differences did not reach statistical significance and appeared to be associated with a few outliers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.